Luciana Maria Silva

Fundação Ezequiel Dias · PE · 19 publicações em 2022–2026

ORCID 0000-0002-2038-0405

Ovarian cancer diagnosis and treatmentCancer Cells and MetastasisBreast Cancer Treatment StudiesParasites and Host InteractionsMicroRNA in disease regulation

Principais coautores no Nordeste tamanho = publicações em comum

Bryan Ôrtero Perez Gonçalves Sílvia Ligório Fialho Letícia da Conceição Braga Milene Pereira Moreira Aline Brito de Lima Bárbara Avelar Ferreira Barros Isabela Nery Tavares Barbosa Andréia Laura Prates Rodrigues Bárbara Danielle Silva Siqueira Bianca Rocha Dos Anjos Daniela de Gouvêa Almada Eliza Pereira Franco

Publicações recentes

2026 2

The dysregulation of a subset of microRNAs in triple-negative breast cancer is associated with poor survival following neoadjuvant chemotherapy
Bioquímica, genética e biologia molecular · Mastology
Potent cytotoxicity of plumbagin targets human glioblastoma and colorectal carcinoma
Farmacologia e toxicologia · Toxicon

2025 4

Ovarian cancer cell heterogeneity and paclitaxel response in vitro 2D and 3D cancer cell models and xenograft growth in the chicken chorioallantoic membrane (CAM)
Medicina · Biochemical and Biophysical Research Communications
Cisplatin treatment induces a shift toward a quiescent Ki-67⁻/CD44⁺/CD133⁺ cancer stem cell subpopulation in a tumorsphere model derived from a murine non-small cell lung cancer cell line
Medicina · Acta Histochemica
The OvarianTag™ Biomarker Panel Emerges as a Prognostic Tool to Guide Clinical Decisions in Cisplatin-Based Treatment of Epithelial Ovarian Cancer
Medicina · International Journal of Molecular Sciences
MACL-1 Breast Cancer Secretome Reprograms Fibroblasts to Enhance Inflammation and Tumor Progression
Medicina · Anais da Academia Brasileira de Ciências

2024 6

TNFRSF10D expression as a potential biomarker for cisplatin-induced damage and ovarian tumor relapse prediction
Medicina · Pathology - Research and Practice
Standard chemotherapy impacts on in vitro cellular heterogeneity in spheroids enriched with cancer stem cells (CSCs) derived from triple-negative breast cancer cell line
Medicina · Biochemical and Biophysical Research Communications
CARACTERIZAÇÃO DO PERFIL IMUNOLÓGICO EM PACIENTES COM CARCINOMA SEROSO DE ALTO GRAU
Medicina · Mário Penna Journal
Investigating the Influence of Everolimus, Recombinant TGF-alpha, and Methotrexate on Cell Cycle Phases in Human Cancer Cell Lines
Medicina · Brazilian Archives of Biology and Technology
Analysis of regulation of cell death pathway genes in CSC-enriched TNBC after treatment with doxorubicin: A potencial biomarker.
Bioquímica, genética e biologia molecular · Journal of Clinical Oncology
TRAIL receptors as prognostic markers and survival predictors in ovarian cancer: A systematic review of clinical studies and meta-analysis
Bioquímica, genética e biologia molecular · Revista Colombiana de Ciencias Químico Farmacéuticas

2023 1

Evaluation of the RDW Index (Red Cell Distribution Width) in Women with Breast Cancer Treated with Doxorubicin in a One-Year Follow-Up Study
Medicina · Diagnostics

2022 6

microRNA miR-133a as a Biomarker for Doxorubicin-Induced Cardiotoxicity in Women with Breast Cancer: A Signaling Pathway Investigation
Medicina · Cardiovascular Toxicology
Low-dose melittin is safe for intravitreal administration and ameliorates inflammation in an experimental model of uveitis
Medicina · Current Research in Pharmacology and Drug Discovery
Markers to sensibility and relapse on IMR-32 neuroblastoma cell line cultured in monolayer (2D) and neurosphere (3D) models cisplatin-treated
Medicina · Acta Histochemica
Pathophysiological Effects of Lycosa erythrognatha Derived Peptide LyeTxI-b on RKO-AS-45-1 Colorectal Carcinoma Cell Line Using the Chicken Chorioallantoic Membrane Model
Medicina · International Journal of Peptide Research and Therapeutics
Níveis de troponina I segundo a classificação molecular do tumor em mulheres com câncer de mama sob uso de doxorrubicina / Troponin I levels according to molecular classification of tumor in women with breast cancer under doxorubicine treatment
Medicina · Brazilian Journal of Health Review
Inhibition of the mToR pathway with everolimus can modulate heat shock genes and ERCC1 gene expression and improves outcomes on serous ovarian cancer in HIPEC in vitro model.
Medicina · Journal of Clinical Oncology

Contagens só com publicações em revistas com Qualis (filtro na tela inicial). Dados obtidos de fontes abertas: OpenAlex (CC0), ROR (CC0), CAPES Dados Abertos (CC-BY), INEP e IBGE. Encontrou um erro sobre você? Saiba mais. Criado por Gabriel Pina.